Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-02-08

Clinical Trial Update: Gabapentin and Chronic Post Surgical Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating gabapentin for chronic post-surgical pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Emory University | Conditions: Pain, Postoperative, Scoliosis Idiopathic | Phase 3 | Status: WITHDRAWN